Professor Bell is a leading clinician and researcher in Cystic Fibrosis (CF). He recently co-led the development of a new global blueprint for the care of people with the fatal genetic disorder. His work will help the 3500 Australians with the incurable condition to live decades longer. Professor Bell has over 250 peer reviewed publications and has received grant support in excess of $22 million over the past 10 years. He is a Senior Thoracic Physician at the Prince Charles Hospital and Editor-in Chief of the Journal of Cystic Fibrosis. Prior to his appointment as TRI CEO, Professor Bell was the Executive Director of Research at Metro North Health and the head of QIMR Berghofer’s Lung Bacteria laboratory.